Vertex (VRTX) Announces Health Canada Acceptance of NDS for Suzetrigine

On May 21, 2026, Vertex Pharmaceuticals (NASDAQ:VRTX) announced that Health Canada accepted for review a New Drug Submission for suzetrigine for the treatment o...